⏳ Fetching live dividend data...
Home › Calculator › BSYI Dividend Calculator 2026
BioSyntech, Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in BSYI → $3.6028976987326526e+64M in 10 years · $3,002,414,734,283,649,400,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
BioSyntech, Inc. is dedicated to developing advanced biotherapeutic thermogels aimed at both repairing tissues and delivering therapeutic compounds. The company's key product pipeline features BST-CarGel, a biodegradable gel designed for cartilage repair; BST-InPod, intended for alleviating heel discomfort; BST-DermOn, for managing and healing chronic wounds; BST-Ossifil, used in bone void filling; BST-Ossifix, which provides structural support for bones; and BST-Disc, focused on restoring intervertebral discs. Beyond these, BioSyntech offers injectable products leveraging BST-Gel technology to precisely deliver biotherapeutics. Its technological assets also include Arthro-BST, an arthroscopic device for the non-destructive evaluation of cartilage degradation or repair, and Mach-1, a micromechanical testing system for assessing the properties of various tissues and materials. The company also manufactures ultra-pure chitosans under the Ultrasan brand and offers both manufacturing and analytical services. Founded in 1994 and based in Laval, Canada, BioSyntech Inc. initiated administration proceedings under the Bankruptcy and Insolvency Act on May 12, 2010, and is currently undergoing reorganization.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BSYI position with:
Real after-tax yield depends on where you live and how you hold BSYI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 17000000.00% | 16999997.20% | $1,700,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 16000000.00% | 15999997.20% | $1,600,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 18250000.00% | 18249997.20% | $1,825,000,000 / yr |
| 🇨🇦 TFSA | 0% | 20000000.00% | 19999997.20% | $2,000,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 15000000.00% | 14999997.20% | $1,500,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 17000000.00% | 16999997.20% | $1,700,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 14000000.00% | 13999997.20% | $1,400,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 14725000.00% | 14724997.20% | $1,472,500,000 / yr |
| 🇫🇷 FR Taxable | 30% | 14000000.00% | 13999997.20% | $1,400,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
BSYI pays quarterly — 4 times per year. Next ex-div: TBD.
How BSYI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BSYI sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BSYI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
BioSyntech, Inc. (BSYI) is currently trading at $0.00, trading near its 52-week low. The current dividend yield is 20000000.00% based on an annual payout of $2.00 per share.
BioSyntech, Inc. (BSYI) is a healthcare stock currently trading at $0.00 with a dividend yield of 20000000.00%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →